14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.30 $2.95 Monday, 22nd Apr 2024 CLLS stock ended at $2.64. This is 3.53% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 2.32% from a day low at $2.59 to a day high of $2.65.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Jun 03, 2021 $15.05 $15.17 $14.18 $14.36 643 687
Jun 02, 2021 $16.04 $16.25 $15.09 $15.20 380 121
Jun 01, 2021 $15.89 $16.53 $15.63 $16.35 259 604
May 28, 2021 $15.49 $16.14 $15.16 $15.67 254 279
May 27, 2021 $15.70 $15.87 $15.04 $15.41 217 000
May 26, 2021 $15.87 $16.39 $15.82 $16.12 104 322
May 25, 2021 $15.88 $16.10 $15.54 $15.72 94 556
May 24, 2021 $15.99 $16.39 $15.70 $15.75 100 161
May 21, 2021 $16.00 $16.67 $15.78 $15.78 169 079
May 20, 2021 $16.29 $16.86 $16.02 $16.21 214 093
May 19, 2021 $15.62 $15.96 $15.32 $15.52 140 718
May 18, 2021 $15.74 $16.64 $15.64 $16.08 127 973
May 17, 2021 $15.46 $15.72 $15.29 $15.55 98 735
May 14, 2021 $14.68 $15.93 $14.68 $15.49 216 996
May 13, 2021 $15.45 $15.72 $14.25 $14.82 413 224
May 12, 2021 $16.03 $16.32 $15.01 $15.28 287 241
May 11, 2021 $15.11 $16.30 $14.84 $15.88 345 194
May 10, 2021 $16.28 $16.28 $14.80 $15.00 355 624
May 07, 2021 $16.08 $17.05 $15.81 $16.30 247 944
May 06, 2021 $16.65 $16.75 $15.36 $15.53 518 821
May 05, 2021 $17.25 $17.61 $16.59 $16.94 196 804
May 04, 2021 $17.91 $17.95 $16.95 $16.99 246 330
May 03, 2021 $18.71 $18.79 $17.97 $18.16 114 709
Apr 30, 2021 $19.29 $19.68 $18.35 $18.61 165 643
Apr 29, 2021 $19.42 $19.46 $18.62 $18.92 220 172
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT